Saturday, September 20, 2025
HomeIndustriesHealthcare

Healthcare

Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

Kintara Therapeutics, Inc.("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that the Company received...

NanoMosaic Partners with BrickBio to Increase its Neurology Content with Novel Tau (Phospho-Thr217) Antibody

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in neurology companion diagnostics (CDx) and future...

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics ("WuXi Bio") , a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility...

CStone and Pfizer Announce NMPA Approval of Sugemalimab in Patients With Unresectable Stage Iii Non-small Cell Lung Cancer

CStone Pharmaceuticals, a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Pfizer Inc. announced that...

One Drop Study Signals Significant Growing Interest in Continuous Glucose Monitors (CGMs) Among People with Type 2 Diabetes (T2D)

One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, presented new research at the 82nd Scientific...
0FansLike
0FollowersFollow
spot_img

Hot Topics